K2fly Limited

As of June 30, 2023, K2fly Limited has 175.31M shares outstanding.

These figures are as of June 30, 2023. The price-to-sales ratio is 1.21, and the price-to-book ratio stands at 1.62.

These figures are as of June 30, 2023. The EV/Sales ratio of 0.89 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. K2fly Limited trades at an EV/FCF ratio of 3.98, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2023, K2fly Limited maintains a current ratio of 0.68, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.63, indicating elevated leverage, while an interest coverage ratio of -39.21 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2023, K2fly Limited posted a negative return on equity (ROE) of -21.12, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -8.92, reflecting losses generated across the asset base.

Over the twelve months ended June 30, 2023, K2fly Limited posted a gross margin of 50.03, reflecting its pricing power and cost economics. The operating margin of -33.06 and net profit margin of -17.25 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2023. Free cash flow yield stands at 17.82, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.27, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to K2fly Limited shareholders.

K2fly Limited's most recent stock split took place on August 23, 2016 with a 47:5 split ratio.

As of June 30, 2023, K2fly Limited has an Altman Z-Score of -4.92, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.